Use of Induction Immunotherapy Plus Rituximab for the Treatment of Pediatric Opsoclonus-Myoclonus Syndrome

被引：0
|
作者：
Wilbur, Colin [1 ]
Yea, Carmen [2 ]
Licht, Christoph [3 ]
Irwin, Meredith [4 ]
Yeh, E. Ann [1 ]
机构：
[1] Hosp Sick Children, Div Neurol, Pediat, Toronto, ON, Canada
[2] SickKids Hosp Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada
[3] Hosp Sick Children, Div Nephrol, Pediat, Toronto, ON, Canada
[4] Hosp Sick Children, Div Hematol Oncol, Pediat, Toronto, ON, Canada
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2.311
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Opsoclonus-Myoclonus syndrome in adults
    Bonnet, L.
    de Bustos, E. Medeiros
    Moulin, T.
    REVUE NEUROLOGIQUE, 2012, 168 (12) : 987 - 988
  • [22] Pharmacodynamics of immunotherapy for opsoclonus-myoclonus syndrome: Impact on cytokines/chemokines
    Pranzatelli, Michael R.
    Tate, Elizabeth D.
    McGee, Nathan R.
    Ransohoff, Richard M.
    CYTOKINE, 2013, 63 (03) : 290 - 290
  • [23] THE NEUROBIOLOGY OF THE OPSOCLONUS-MYOCLONUS SYNDROME
    PRANZATELLI, MR
    CLINICAL NEUROPHARMACOLOGY, 1992, 15 (03) : 186 - 228
  • [24] Opsoclonus-myoclonus syndrome in children
    Bembeeva, R. Ts.
    Petrukhin, A. S.
    Bologov, A. A.
    Baidun, L. V.
    Il'Ina, E. S.
    Samoilova, M. V.
    Kolpakchi, L. M.
    Semykina, L. I.
    Fedonyuk, I. D.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2007, 107 (02) : 4 - 11
  • [25] RITUXIMAB AS A TREATMENT FOR REFRACTORY OPSOCLONUS-MYOCLONUS SYNDROME (OMS) IN NEUROBLASTOMA PATIENTS: A CASE SERIES
    Toyohara, Miwako
    Kiyotani, Chikako
    Morita, Mari
    Yasue, Shiho
    Yamada, Yuji
    Deguchi, Takao
    Miyazaki, Osamu
    Yoshioka, Takako
    Yoneda, Akihiro
    Matsumoto, Kimikazu
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S15 - S16
  • [26] Selective Mutism in Pediatric Opsoclonus-Myoclonus Syndrome: A Case Study
    Choate, Alyssa Zwicker
    Wahlberg, Andrea
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2022, 37 (06) : 1320 - 1320
  • [27] Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus
    Bell, Jessica
    Moran, Cassandra
    Blatt, Julie
    PEDIATRIC BLOOD & CANCER, 2008, 50 (02) : 370 - 371
  • [28] Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome
    Pranzatelli, Michael R.
    Tate, Elizabeth D.
    Mcgee, Nathan R.
    MacArthur, Craig A.
    PEDIATRIC NEUROLOGY, 2018, 85 : 71 - 75
  • [29] Treatment of idiopathic opsoclonus-myoclonus syndrome with intravenous immunoglobulin
    Unal, A
    Sumer, MM
    Atasoy, HT
    Atasoy, N
    NEUROLOGY INDIA, 2004, 52 (04) : 520 - 521
  • [30] IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome
    Beck, S.
    Fuehlhuber, V.
    Krasenbrink, I.
    Tschernatsch, M.
    Kneifel, N.
    Kirsten, A.
    Jaeger, C.
    Kaps, M.
    Preissner, K. T.
    Lang, B.
    Rostasy, K.
    Blaes, F.
    JOURNAL OF NEUROIMMUNOLOGY, 2007, 185 (1-2) : 145 - 149
12345